TGA Approval

FLUCLOXACILLIN KABI flucloxacillin 500 mg (as sodium) powder for injection vial (340130)

ARTG ID

340130

ARTG Name

FLUCLOXACILLIN KABI flucloxacillin 500 mg (as sodium) powder for injection vial

Sponsor

Fresenius Kabi Australia Pty Ltd

ARTG Date

June 7, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Fresenius Kabi Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/ecfd4f0c2873cabccd25f1db9c3a381b.pdf

https://medical-cdn.nocode.com/drug_tga/e423ae42e7b2ef195a1161a6f5856a56.pdf

Ingredient Name

flucloxacillin sodium monohydrate

Empowering clinical research with data-driven insights and AI-powered tools.

FLUCLOXACILLIN KABI flucloxacillin 500 mg (as sodium) powder for injection vial (340130) - TGA 批准文号 | MedPath